• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS US. CORP PRECISE PRO RX; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS US. CORP PRECISE PRO RX; STENT, CAROTID Back to Search Results
Catalog Number PC0940RXC
Device Problem Difficult or Delayed Positioning (1157)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/11/2023
Event Type  malfunction  
Event Description
As reported, the 9x40 precise pro was inserted into intracranial.However, the outer sheath was unable to be retracted during deployment.The complaint device was replaced with another precise pro (same catalog number/ different lot number).There was no reported injury to the patient.The device will be returned for evaluation.Additional information was requested about returned device; however, the information was not obtained after multiple attempts.
 
Manufacturer Narrative
Additional information is pending and will be submitted within 30 days upon receipt.
 
Manufacturer Narrative
As reported, the 9x40 precise pro was inserted into intracranial.However, the outer sheath was unable to be retracted during deployment.The complaint device was replaced with another precise pro (same catalog number/ different lot number).There was no reported injury to the patient.Additional information was requested about returned device; however, the information was not obtained after multiple attempts.The device was returned for analysis.A non-sterile ¿precise pro rx ous carotid sys¿ was received for analysis coiled inside of a clear plastic bag.The device was unpacked and placed on a metallic tray to be inspected.A thorough inspection was performed on the unit observing the following conditions.The device is fully deployed, and the stent was not retuned for analysis.The hemostasis valve was returned tightly closed.No other outstanding details were observed.Dimensional analysis was performed, the stroke length was measured along with the usable length and both results were found within specification.Functional testing was not performed as the unit was returned and the stent fully deployed and not returned with the sds.However, the mechanism was verified setting the device in the manufacturing condition to simulate the stent deployment process.The mechanism was deployed observing no anomalies during the functional testing.The failure reported by the customer as ¿stent delivery system (sds) deployment difficulty-unable¿ was not confirmed as the unit was returned without the stent.Additionally, the device passed dimensional analysis as the stroke and usable lengths were found within specification.Secondary findings of ¿stent delivery system (sds) deployment difficulty premature deployment¿ was confirmed as the device was returned with the stent fully deployed, there was no stent present.Functional analysis could not be performed as the stent was not received with the device; however, functionality of the deployment mechanism was tested with no difficulties noted.Additionally, no kinks or other damages were noted to the device upon analysis.Therefore, based on the information available for review, limited procedural information provided and the product analysis, it is not possible to determine what factors may have contributed to the issue experienced by the customer.According to the instructions for use, which is not intended to mitigate risk, ¿extract the stent delivery system from the tray.Examine the device for any damage.Evaluate the distal end of the catheter to ensure that the stent is contained within the outer sheath.Do not use if the stent is partially deployed.Note: if resistance is met during delivery system introduction, the system should be withdrawn and another system should be used.Note: if any resistance is met during delivery system withdrawal, advance the outer sheath until the outer sheath marker contacts the catheter tip and withdraw the system as one unit.Initiate stent deployment by retracting the outer sheath while holding the inner shaft in a fixed position.Deployment is complete when the outer sheath marker passes the proximal inner shaft stent marker.Note: the mechanism for stent deployment is outer sheath retraction.Deployment is completed by maintaining inner shaft position while retracting the outer sheath and allowing the stent to expand (often referred to as the ¿pin-and-pull¿ method).Post-deployment stent dilatation: while using fluoroscopy, withdraw the entire delivery system as one unit, over the guidewire and out of the body.Remove the delivery device from the guidewire.Note: if any resistance is met during delivery system withdrawal, advance the outer sheath until the outer sheath marker contacts the catheter tip and withdraw the system as one unit.(do not remove guidewire.) using fluoroscopy, visualize the stent to verify full deployment.If incomplete expansion exists within the stent at any point along the lesion, post deployment balloon dilatation (standard pta technique) can be performed.¿ the information available does not suggests a design or manufacturing related cause for the reported event.Therefore, no corrective or preventive action will be taken at this time.
 
Event Description
As reported, the 9x40 precise pro was inserted into intracranial.However, the outer sheath was unable to be retracted during deployment.The complaint device was replaced with another precise pro (same catalog number/ different lot number).There was no reported injury to the patient.The device will be returned for evaluation.Additional information was requested about returned device; however, the information was not obtained after multiple attempts.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRECISE PRO RX
Type of Device
STENT, CAROTID
Manufacturer (Section D)
CORDIS US. CORP
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer (Section G)
CORDIS US CORP.
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer Contact
karla castro
santiago troncoso 808
juarez, chihuahua 
7863138372
MDR Report Key18586951
MDR Text Key333842498
Report Number9616099-2024-00034
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/26/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Catalogue NumberPC0940RXC
Device Lot Number18169176
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/27/2023
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/25/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/02/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
PRECISE PRO RX US CAROTID SYST; UNKNOWN SHEATH
Patient RaceAsian
-
-